7 Hot Stocks Take Over As Palantir Drops In Troubling Sell-Off

Blockhead
Aug 20

Can you believe it? Red-hot AI stock Palantir (PLTR) is dropping. But don't worry, plenty of S&P 500 stocks are stepping up to fill the void.

Shares of seven S&P 500 stocks, including Dayforce (DAY), Paramount Skydance (PSKY) and UnitedHealth Group (UNH), jumped 10% or more since Palantir shares peaked on Aug. 12, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.

Palantir stock is the absolutely worst-performing S&P 500 stock in that time: falling more than 15%. That puts the individual stock well into a correction and close to a bear.

Some are starting to wonder if pricey, high-growth stocks are taking a breather and allowing other parts of the market to catch up. "The key question is: at what point do valuations become punitive? That's when we may start to see real rotation and broadening," said Mark Malek, chief investment officer at Siebert Financial.

Worst To First

A portion of the S&P 500 rotation is back into stocks that had been punished. UnitedHealth Group is a case in point.

Shares of the health insurer are down 40% this year through Aug. 12, making them one of the worst performers in the S&P 500. But they've soared more than 15% since then, turning UnitedHealth into the third-best stock since Palantir peaked.

Certainly, the purchase of the stock by Berkshire Hathaway's Warren Buffett helped. The stock, though, needs more than a weeklong rise to recover. Its RS Rating is just 8 and EPS Rating isn't great either at 59. Plus, analysts think the company's profit will fall 41% this year.

Not Just 'Cheap' Stocks Are Rallying

Interestingly, though, the best performer amid the Palantir crash is another richly valued stock: Dayforce. The HR and payroll services firm has seen its stock surge nearly 28% during the Palantir tumble.

And Dayforce isn't a cheap stock like UnitedHealth. It sports a trailing valuation on adjusted earnings of 222 times. That's at least 10-times higher than the valuation on the S&P 500. And while its RS Rating of 65 isn't great, it also sports a solid EPS Rating of 98.

Analysts think Dayforce's profit will rise 22% this year and 14% next year.

And investors also seem enamored with what's going on at Paramount Skydance. The media company is the product of the just-approved takeover of Paramount by Entertainment firm Skydance.

Shares are up 22% just during Palantir's sell-off. But the shares of Paramount Skydance are up 28.2% this year so far. Its RS Rating is hanging tough at 84. Earnings, though, are a work in progress. The EPS Rating is just 17. Analysts see profit dropping 16% in 2025. But they're hoping for a 10% jump in 2026.

It's unclear if Palantir's sell-off is just a short-term blip. But it's very clear other S&P 500 stocks are ready to step up.

Top S&P 500 Stocks During Palantir Sell-Off

Palantir is down 15.5% since Aug. 12, 2025

Company Ticker % ch. Aug. 12 to now Sector
Dayforce DAY 27.3% Industrials
Paramount Skydance PSKY 21.5% Communication Services
UnitedHealth Group UNH 16.0% Health Care
Intel INTC 15.7% Information Technology
First Solar FSLR 14.0% Information Technology
Centene CNC 11.3% Health Care
Molina Healthcare MOH 10.3% Health Care
Sources: IBD, S&P Global Market Intelligence

Follow Matt Krantz on X (Twitter) @mattkrantz

YOU MAY ALSO LIKE:

Two Of The World's Richest Men Loaded Up On The Exact Same Stock

Learn How To Time The Market With IBD's ETF Market Strategy

Find Today's Best Growth Stocks To Watch With IBD 50

Join IBD Live Each Morning For Stock Tips Before The Open

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10